Merck News Item

Links shared publicly online about this topic.

  • 1,973
    total visits

Merck News Item

merck.com

Merck News Item

View full resource at merck.com

Tags: Asthma Medication, Singulair, Merck & Co.

  • Share

Most Recently Shared on June 13, 2009 at 1:15 pm By:

wheezemd Michael Blaiss, MD

Will the new Singulair label on neuropsychiatric events modify its use? I don't think as long as patients are informed. http://is.gd/10KMs

3 years ago...

Allergy Alert on Undeclared Milk in Knott's Berry Farm Cookies - Southern Maryland News, Charles County, Calvert County and St. Mary's County News

thebaynet.com — “Biscomerica Corp. is recalling its Knott's Berry Farm 12/8/2 display cartons as described in our product description (item numbers # 59680 Boysenberry, #59675 Blueberry, # 59670 Raspberry and # 59695 Strawberry). Each carton contains eight 2 ounce packages of Knott's Berry Farm cookiesView full resource at thebaynet.com

  • View Related
  • Share

Most Recently Shared on April 10, 2012 at 10:01 pm By:

_gluten_free Allergydiet Health Business

Allergy Alert on Undeclared Milk in Knott's Berry Farm Cookies http://t.co/4b9rw1jk

6 days ago...

P.F. Chang’s Expanding Gluten-Free Menu

celiac-disease.com — “P.F. Chang’s has always been a favorite gluten-free dining spot for us.  Not only do they offer a nice variety of choices, they have an outstanding glutView full resource at celiac-disease.com

  • View Related
  • Share

Most Recently Shared on March 29, 2012 at 12:00 pm By:

CeliacResearch Celiac Research Health Organization

RT @glutenfreeworks: GREAT news! PF Changs is adding to their Gluten-Free Menu! http://t.co/TIU0rvY4

3 weeks ago...

Dr. Mintz' Blog: Questions Are the Answer

drmintz.blogspot.com — “A physician's perspective on recent medical items from the news and mediaView full resource at drmintz.blogspot.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 5:29 pm By:

drmintz drmintz Doctor, Internist, and Physician

Questions Are the Answer: One of the advantages of having a blog has given me incredible opportunities to works ... http://t.co/mCxmPJyB

3 weeks ago...

News in brief - March 26, 2012 - amednews.com

ama-assn.org — “'' and other itemsView full resource at ama-assn.org

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 4:29 pm By:

amednews AmericanMedicalNews Health Organization and Health News

Virginia law would let plaintiffs sue over fetus deaths http://t.co/4qKjSV4B

3 weeks ago...

Caution Urged in Moving More Drugs OTC : ACEP NEWS

acepnews.com — “ACEP News offers real-time clinical news, news from the American College of Emergency Physicians, and news on practice trends and health care reform for the emergency medicine physician. Features include In The Arena by Dr. David Baehren, the CME feature called Focus On, and the practical guide to ED procedures called Tricks of the Trade. Specialty Focus items include Cardiovascular Disorders, Dermatologic Disorders, Imaging, Infectious Diseases, Metabolic & Endocrine Disorders, Neurologic DisorView full resource at acepnews.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 4:16 pm By:

ACEPNews Nancy Calaway Medical Society and Medical Journal

Caution Urged in Moving More Drugs OTC: Although expanding nonprescription access to some medications could be b... http://t.co/qwyuuPgC

3 weeks ago...

In TRA-2P Study, Adding Merck's Vorapaxar to Standard of Care Significantly Reduced the Risk of Cardiovascular Events - Drugs.com MedNews

drugs.com — “Results Published in the Online Edition of the New England Journal of Medicine and Presented at American College of Cardiology Scientific Session Merck ContinueView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 12:06 pm By:

Drugs_Devices Drugs and Devices OW OW Health

In TRA-2P Study, Adding Merck's Vorapaxar to Standard of Care Significantly Reduced the Risk of Cardiovasc... http://t.co/8XlE5VFG #drug

3 weeks ago...

Merck ponders next step for troubled heart drug

cfnews13.com — “Merck ponders next step for troubled heart drugView full resource at cfnews13.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 12:52 pm By:

tomheston Tom Heston, MD Family Medicine Doctor, Physician, and Doctor

Merck ponders next step for troubled heart drug - Central Florida News 13 http://t.co/vaFWv8z3 #medicine

3 weeks ago...

Perk Valley district looks to self-insure to save money -Spring-Ford Reporter Valley Item - Montgomery News

montgomerynews.com — “Montgomery News is your source for all Montgomery County 24-hour breaking news, local news, sports, entertainment and more. View weather updates, watch videos and photos. Keep up with News and local Sports. Find restaurants, entertainment, cars, homes and jobs at Montgomery News.View full resource at montgomerynews.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 8:05 am By:

HealthInsure_OW Health Insurance OW OW Health

Perk Valley district looks to self-insure to save money: PERKIOMEN - The Perkiomen Valley School District is mov... http://t.co/aVMVHyxe

3 weeks ago...

Merck's Blood Thinner Shows Reduced Heart Events, But Increased Bleeding

rttnews.com — “Drugmaker Merck & Co. (MRK) Saturday said its experimental blood thinner vorapaxar in combination with standard of care was seen to significantly reduce cardio vascular events in heart patients, but saw an increase in bleeding especially in those who have had a stroke.View full resource at rttnews.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 5:05 am By:

tomheston Tom Heston, MD Family Medicine Doctor, Physician, and Doctor

Merck's Blood Thinner Shows Reduced Heart Events, But Increased Bleeding - RTT News http://t.co/yedpZo95 #health

3 weeks ago...

Merck blood clot drug in limbo after mixed results - chicagotribune.com

healthcare.tweetmeme.com — “All the news on healthcareView full resource at healthcare.tweetmeme.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 8:41 pm By:

Merck ponders next step for troubled heart drug - Yahoo! News

news.yahoo.com — “From Yahoo! News: Officials at drugmaker Merck & Co. say they will take more time to decide what to do about an experimental blood thinner that gave disappointing results in a second big study.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 6:59 pm By:

Doctorwisdom2 OrganizedWisdom OW Health

Merck ponders next step for troubled heart drug: Officials at drugmaker Merck & Co. say they will take more time... http://t.co/ZJ4KHKLQ

3 weeks ago...

Merck blood thinner shows mixed results: study - Yahoo! News

news.yahoo.com — “From Yahoo! News: An experimental blood thinning drug made by the pharmaceutical giant Merck may reduce the risk of dying from a heart attack but also boosts the danger of internal bleeding, researchers said Saturday.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 6:30 pm By:

HealthTrendster HealthTrendster Health Executive

Merck 'blood thinner' shows mixed results: study - An experimental blood thinning drug made by the pharmaceutical gi... http://t.co/ehl1QPJo

3 weeks ago...

Merck blood clot drug in limbo after mixed results - Yahoo! News

news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, researchers said on Saturday, raising questions whether the company will seek approval of the drug and whether it can pass muster with regulators. Vorapaxar has been dogged by bleeding concerns since January 2011, when a safety committee overseeing the 26,449-patient study said the new type oView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 3:52 pm By:

Doctorwisdom2 OrganizedWisdom OW Health

Merck blood clot drug in limbo after mixed results: CHICAGO (Reuters) - Impressive efficacy but worrisome bleedi... http://t.co/V3CP4aUx

3 weeks ago...

Merck blood clot drug in limbo after mixed results - Yahoo! News

news.yahoo.com — “From Yahoo! News: CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding was seen for a new type of blood clot preventer tested by Merck & Co in one of the largest heart-drug studies ever conducted, raising questions whether the company will seek approval of the drug and whether it can pass muster with regulators, researchers said on Saturday. Vorapaxar has been dogged by bleeding concerns since January 2011, when a safety committee overseeing the 26,449-patient study said the new type oView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 2:34 pm By:

HealthTrendster HealthTrendster Health Executive

Merck blood clot drug in limbo after mixed results - CHICAGO (Reuters) - Impressive efficacy but worrisome bleeding ... http://t.co/CSjRsD5J

3 weeks ago...

Merck ponders next step for troubled heart drug - Yahoo! News

news.yahoo.com — “From Yahoo! News: Officials at drugmaker Merck & Co. say they will take more time to decide what to do about an experimental blood thinner that gave disappointing results in a second big study.View full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 2:34 pm By:

HealthTrendster HealthTrendster Health Executive

Merck ponders next step for troubled heart drug - Officials at drugmaker Merck & Co. say they will take more time to... http://t.co/1ha9CHhC

3 weeks ago...

Advertisement